On Friday, Piper Sandler initiated coverage on Primerica (NYSE:NYSE:PRI) stock, setting a Neutral rating with a price target of $283.00.
The firm highlighted Primerica's focus on a specific market niche, offering investment and protection products to the low-and-middle-income demographic, as a strength. This specialized approach, combined with the company's robust sales force and culture, is seen as contributing to higher returns and valuations.
The price target set by Piper Sandler suggests that Primerica's shares are currently fairly valued. The target is based on a projected 14.0x earnings multiple for the year 2025, which is above both the 5-year average multiple of 11.5x and the 10-year average of 12.1x. This valuation reflects the firm's expectation of improved returns for Primerica.
Primerica's recent decision to exit the senior health business, specifically the e-TeleQuote acquisition made in 2021, is viewed as a strategic move to decrease earnings volatility.
Piper Sandler believes that this exit will help maintain Primerica's return profile, which is anticipated to be significantly above the average of its coverage universe, with an expected return on equity excluding accumulated other comprehensive income (ROExAOCI) of 29.2% for 2025 compared to the coverage universe average of 16.1%.
According to Piper Sandler, this strategic focus and financial profile could, over time, lead to Primerica's valuation resembling that of a distributor rather than a traditional life insurance company. The firm's outlook is based on the company's defined niche and its potential for sustained higher returns.
In other recent news, Primerica, Inc. has reported a robust financial performance for the second quarter of 2024, marked by a 12% year-over-year growth in adjusted net operating income and an 18% increase in per-share operating income.
The company also saw a 12% increase in recruitment, adding over 96,000 new individuals, and a 14% growth in new life licensing. In addition to these achievements, sales in investment and savings products jumped by 29% to $3.1 billion.
On the other hand, Primerica announced its decision to exit the senior health market due to regulatory challenges. Despite this, the company expects a full-year growth rate of 5% to 6%.
The mortgage business is also expanding, with about 3,000 mortgage loan originators in the U.S. These are among the recent developments in the company's operations.
It's also worth noting that Primerica's convention drew nearly 40,000 attendees, a promising sign for continued growth. The company's annual assumption review in Q3 is expected to provide further insights into financial trends.
InvestingPro Insights
Primerica's commitment to its niche market is underscored by its consistent dividend growth, a positive sign for investors looking for stability. According to InvestingPro Tips, Primerica has raised its dividend for 14 consecutive years and has maintained dividend payments for 15 consecutive years. This track record of returning value to shareholders complements Piper Sandler's neutral outlook and supports the potential for sustained higher returns.
InvestingPro Data further reveals Primerica's solid financial standing. With a market capitalization of $8.85 billion and a Price/Earnings (P/E) ratio of 20.83, which adjusts to 14.0 on a forward-looking basis, the company's valuation metrics are robust. This is further evidenced by a healthy revenue growth of 8.67% over the last twelve months as of Q2 2024. Moreover, Primerica's operating income margin stands at an impressive 30.4%, indicating efficient management and profitability.
For investors seeking additional insights, there are over 10 more InvestingPro Tips available for Primerica, which can be found at https://www.investing.com/pro/PRI. These tips provide a deeper understanding of the company's financial health and market position, aiding in making informed investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.